United States Pharmacopeia - India Private Limited - Company Profile

It is a pharma private limited company based in Shameerpet Hyderabad, Telangana, India, established in 2005.

2005 Shameerpet Hyderabad, Telangana, India Active

Last Updated: December 17, 2025

About United States Pharmacopeia - India Private Limited

United States Pharmacopeia - India Private Limited, a active private limited company, was established on 27 May 2005 in Shameerpet Hyderabad, Telangana, India. Engaging in drug formulation & development within the education sector, it holds CIN: U24230TG2005PTC046362. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹36.39 Cr.

It upholds a compliant status. Its leadership includes Girish Kapur (Director), Mrunal Atul Jaywant (Additional Director), Amanda Dawn Cowley (Director). Past directors included Brian Lee Hendrix, John Thomas Fowler, Steve Mendelsohn. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot Nod6&D8, (Survey No 234/2,234/3,235/2& 542/2) Turkapally Village Ikp Knowledgepark Gen, Ome Valley, Shameerpet Hyderabad, Telangana, 500078.

Company Details

CIN/LLPIN
U24230TG2005PTC046362
Registration Number
046362
Incorporation Date
27 May 2005
Authorized Capital
₹50.00 Cr
Paid-Up Capital
₹36.39 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 50.00 Cr as on 17-12-2025
Paid Up Capital ₹ 36.39 Cr as on 17-12-2025
Company Age 20 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 9.40% (FY 2022)
Profit Growth **** 33.76% (FY 2022)
Ebitda **** 28.08% (FY 2022)
Net Worth -17.14% (FY 2022)
Total Assets -16.97% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into United States Pharmacopeia - India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at United States Pharmacopeia - India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Girish Kapur	Director	31 Dec 2019	Current
Mrunal Atul Jaywant	Additional Director	03 Sep 2021	Current
Amanda Dawn Cowley	Director	20 Dec 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Jun 2013	Past
Pramod Abcsdd	Director	01 Dec 2009	Past
Pramod Abcsdd	Director	31 Dec 2008	Past
Pramod Abcsdd	Director	22 Apr 2015	Past
Pramod Abcsdd	Additional Director	30 Sep 2014	Past
Pramod Abcsdd	Additional Director	30 Sep 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of United States Pharmacopeia - India.

United States Pharmacopeia - India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.4% increase. The company also saw a substantial improvement in profitability, with a 33.76% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.14%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

9.40%

*******

Revenue from Operations

*******

9.55%

*******

Total Assets

*******

-16.97%

*******

Profit or Loss

*******

33.76%

*******

Net Worth

*******

-17.14%

*******

EBITDA

*******

28.08%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of United States Pharmacopeia - India?

In 2023, United States Pharmacopeia - India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at United States Pharmacopeia - India?

Unlock and access historical data on people associated with United States Pharmacopeia - India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of United States Pharmacopeia - India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped United States Pharmacopeia - India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on United States Pharmacopeia - India

Recent Activity within the Organization

Director Appointment

The activity Aradhana Dilip Rewatkar was appointed as a Company Secretary was appointed as a Company Secretary on 10 Oct 2025 & has been associated with this company since 4 months 21 days . was completed.
10 Oct 2025
Annual General Meeting

The activity United States Pharmacopeia - India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

The activity United States Pharmacopeia - India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Director Appointment

Progress on Mrunal Atul Jaywant was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2021 & has been associated with this company since 4 years 5 months . was documented.
03 Sep 2021
Director Appointment

The activity Girish Kapur was appointed as a Director was appointed as a Director on 31 Dec 2019 & has been associated with this company since 6 years 2 months . was completed.
31 Dec 2019
Director Appointment

Amanda Dawn Cowley was appointed as a Director was appointed as a Director on 20 Dec 2017 & has been associated with this company since 8 years 2 months . was recorded as a recent event.
20 Dec 2017

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of United States Pharmacopeia - India Private Limited?

The CIN of United States Pharmacopeia - India Private Limited is U24230TG2005PTC046362.

Where is United States Pharmacopeia - India Private Limited headquartered?

United States Pharmacopeia - India Private Limited is headquartered at Plot Nod6&D8, (Survey No 234/2,234/3,235/2& 542/2) Turkapally Village Ikp Knowledgepark Gen, Ome Valley, Shameerpet Hyderabad, Telangana, 500078.

When was United States Pharmacopeia - India Private Limited incorporated?

United States Pharmacopeia - India Private Limited was incorporated on 27 May 2005.

Who are the current directors of United States Pharmacopeia - India Private Limited?

The current directors of United States Pharmacopeia - India Private Limited are

What is the primary industry of United States Pharmacopeia - India Private Limited?

The primary industry of United States Pharmacopeia - India Private Limited is Education.

Is United States Pharmacopeia - India Private Limited a listed company?

United States Pharmacopeia - India Private Limited is unlisted.

What is the capital structure of United States Pharmacopeia - India Private Limited?

The authorized capital of United States Pharmacopeia - India Private Limited is ₹50.00 Cr, and the paid-up capital is ₹36.39 Cr.

What is the compliance status of United States Pharmacopeia - India Private Limited?

The compliance status of United States Pharmacopeia - India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available